Addressing Opioid Dependency: Trends and Insights in the Opioid Drugs Market Pronounce Growth in Upcoming Years|Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited

Market Overview:

Opioid drugs are prescribed to treat moderate to severe pain. Common opioid drugs include oxycodone, hydrocodone, codeine, morphine, fentanyl and others. They work by binding to opioid receptors in the brain and body to reduce the intensity of pain signals reaching the brain.

Market Dynamics:

The opioid drugs market is expected to witness moderate growth driven by the increasing prescription of opioid medications for management of acute and chronic pain. As per the Center for Disease Control and Prevention (CDC), around 20% of patients presenting to physician offices with complaints of pain receive an opioid prescription. Also, rising prevalence of lifestyle diseases such as arthritis has led to growing cases of chronic joint pain and musculoskeletal injuries, thereby fueling adoption of opioid drugs. Further, introduction of long-acting opioid formulations is supporting compliance to therapy and boosting the market size. However, stringent regulations to curb opioid misuse and abuse along with development of effective non-opioid therapy options are expected to hamper market growth over the forecast period.

Get an Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/1017

Rising Abuse of Prescription Opioids is Driving the Market Growth

The abuse of prescription opioid drugs has significantly increased over the past decade. According to the National Institute on Drug Abuse, around 11.4 million Americans misused prescription opioids in 2018. This points to the rising demand for these drugs for unintended purposes and not medical treatment alone. Consequently, pharmaceutical companies manufacturing opioid drugs have witnessed higher sales and profits. To keep up with this consumer behavior, companies are investing more in R&D, expanding their product portfolios, and enhancing distribution networks to tap new customers and markets.

Increasing Demand in Pain Management is Prompting Market Growth

Globally, the cases of chronic pain such as back pain, arthritis, cancer pain etc. have risen dramatically in the last few years due to sedentary lifestyles and aging populations. Opioid drugs are extensively used in palliative care and pain management for conditions that do not respond well to other therapies. With limited treatment options available, the demand for various opioid formulations like transdermal patches, oral tablets, and injectables used in long-term pain management has surged significantly. Drug makers are actively developing novel drug delivery methods and novel molecules to target this growing requirement.

Over-prescription of Opioids by Doctors Poses Risk of Addiction and is a Major Market Restraint

While opioid drugs play an important role in pain management, over-prescription by doctors has led to addiction issues in many patients. Easy access to these highly potent analgesics through legal prescriptions increased the chance of misuse and abuse. According to estimates, up to 29% of patients prescribed opioids for chronic pain misuse them. This poses serious health hazards like overdose and higher mortality rates. Growing awareness about addiction risks and tightening of regulations have made doctors cautious about prescribing practices. Some countries have imposed limits or restrictions on opioid prescriptions that can negatively impact sales.

Developing Long-acting Formulations can be a Lucrative Market Opportunity

Long-acting or extended-release opioid formulations that require less frequent dosing and have lower addiction risks than short-acting versions present a major business opportunity. These extended formulations help in maintaining around-the-clock pain relief and consistent drug levels in the bloodstream. Currently, transdermal patches and long-acting injectables dominate this category. Companies innovating novel drug delivery technologies like implants, depot injections, and responsive drug delivery systems can gain an edge in the market. The lucrative long-acting segment with fewer substitution threats will attract investments from manufacturers.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/1017

Personalized Pain Medicines will Drive Future Market Trends

With growing knowledge about genetic differences in individual pain perception and drug response, there is increased focus on developing personalized pain therapies. Companies are devoting R&D efforts into tailoring existing drugs or developing new molecules targeting specific genetic biomarkers of pain. Other emerging trends include multi-modal options combining opioids with non-opioid analgesics or adjunctive therapies. Also, the rise of digital health tools and telehealth consultations that help manage pain at home with remote monitoring can transform pain care pathways. Such personalized or precision pain approaches address unmet needs and sidelining addictive risks will influence future opioid drug market trends.

Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, a detailed analysis of the competitive landscape, and product services of key players. Analysis of Opioid Drugs companies, key tactics followed by Leading Key Players:

◘ Teva Pharmaceutical Industries Ltd.
◘ Johnson & Johnson
◘ Endo International plc
◘ Lupin Limited
◘ Cadila Healthcare Limited
◘ Purdue Pharma L.P.
◘ AbbVie Inc.
◘ Fresenius Kabi
◘ Mallinckrodt Pharmaceuticals
◘ Pfizer Inc.
◘ Rhodes Pharmaceuticals L.P.
◘ Sun Pharmaceutical Industries Limited
◘ Nesher Pharmaceuticals (USA) LLC
◘ Amneal Pharmaceuticals LLC
◘ Trevena Inc.
◘ Aurobindo Pharma Limited.

Note: Major Players are sorted in no particular order.

By Drug Class: Alkaloids (Morphine, codeine), Semisynthetic Opioids (Oxycodone, Hydrocodone, Hydromorphone), Synthetic Opioids (Fentanyl, Alfentanil)

By Application: Analgesia, Cough Suppression, Diarrhea Suppression, Others

By Route of Administration: Oral, Topical, Parenteral, Others (Intramuscular, etc.)

By Distribution Channel : Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The Study Objectives are:

A comprehensive insight into key players operating in the Opioid Drugs Market and their corresponding data.
It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
Regional analysis, which includes insight into the dominant market and corresponding market share.
It also includes various socio-economic factors affecting the evolution of the market in the region.
The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Contents:

Market scenario 2023

Chapter 1: Introduction, Market Driving Force Product Objective of Study and Research Scope the Opioid Drugs market
Chapter 2: Exclusive Summary - the basic information of the Opioid Drugs Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends, and Challenges & Opportunities of the Opioid Drugs
Chapter 4: Presenting the Opioid Drugs Market Factor Analysis, Supply/Value Chain, PESTEL analysis, Market Entry, and Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User, and Region/Country 2023 - 2030
Chapter 6: Evaluating the leading manufacturers of the Opioid Drugs market which consists of its Competitive Landscape, Peer Group Analysis, Market positioning & Company Profile
Chapter 7: To evaluate the market by segments, by countries, and by Manufacturers/Companies with revenue share and sales by key countries in these various regions (2023-2030)
Chapters 8 & 9: Displaying the Appendix, Methodology, and Data Source

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/1017

Key Questions Answered:

What is the market size and CAGR of the Opioid Drugs Market during the forecast period?
How is the growing demand impacting the growth of Opioid Drugs Market shares?
What is the growing demand of the Market during the forecast period?
Who are the leading vendors in the market and what are their market shares?
What is the impact of the COVID-19 pandemic on the APAC Opioid Drugs Market?

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.